Abstract
BACKGROUND: Continuous glucose monitoring (CGM) has come a long way and is standard for patients with type 1 diabetes and many with type 2 diabetes. Several attempts to establish noninvasive glucose monitoring, that is, measuring glucose without puncturing the skin, have not been successful yet.
METHOD: A different approach is the monitoring of volatile organic compounds in breath.
RESULTS: This addresses a number of limitations of current invasive glucose monitoring techniques. This should enhance compliance, adherence, clinical outcomes, and quality of life. It might also reduce costs associated with CGM.
CONCLUSIONS: A recent publication in this journal indicates the clinical value of this approach by presenting data from a clinical study. The respective pros and cons will be discussed briefly.
| Original language | English |
|---|---|
| Pages (from-to) | 19322968261427022 |
| Number of pages | 3 |
| Journal | Journal of Diabetes Science and Technology |
| Early online date | 28 Feb 2026 |
| DOIs | |
| Publication status | Published - 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Fields
- Metabolism and Circulation
Fingerprint
Dive into the research topics of 'The Potential Role of Noninvasive Glucose Monitoring in the Management of People with Type 2 Diabetes.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver